Statera Biopharma, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Statera Biopharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2022.
  • Statera Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$3.35M, a 73.7% increase year-over-year.
  • Statera Biopharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$91.8M, a 205% decline year-over-year.
  • Statera Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$102M, a 742% decline from 2020.
  • Statera Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$12.1M, a 357% decline from 2019.
  • Statera Biopharma, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$2.65M, a 26.7% increase from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$91.8M -$3.35M +$9.37M +73.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$101M -$3.49M +$3.12M +47.2% Apr 1, 2022 Jun 30, 2022 10-Q 2022-10-28
Q1 2022 -$104M -$7.76M -$2.47M -46.7% Jan 1, 2022 Mar 31, 2022 10-Q 2022-10-21
Q4 2021 -$102M -$77.2M -$71.8M -1316% Oct 1, 2021 Dec 31, 2021 10-K 2022-10-06
Q3 2021 -$30.1M -$12.7M -$7.04M -124% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$23M -$6.61M -$6.24M -1686% Apr 1, 2021 Jun 30, 2021 10-Q 2022-10-28
Q1 2021 -$16.8M -$5.29M -$4.7M -798% Jan 1, 2021 Mar 31, 2021 10-Q 2022-10-21
Q4 2020 -$12.1M -$5.46M -$4.75M -671% Oct 1, 2020 Dec 31, 2020 10-K 2022-10-06
Q3 2020 -$7.34M -$5.68M -$5.23M -1162% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2.12M -$370K +$247K +40% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$2.36M -$589K +$284K +32.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$2.65M -$707K -$275K -63.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$2.37M -$450K +$655K +59.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$3.03M -$617K +$234K +27.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$3.26M -$873K +$352K +28.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$3.61M -$432K Oct 1, 2018 Dec 31, 2018 10-K 2020-04-15
Q3 2018 -$1.1M +$156K +12.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$851K +$4.76M +84.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$1.22M +$439K +26.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q3 2017 -$1.26M -$2.4M -211% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$5.61M -$3.71M -196% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$1.66M -$996K -149% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 $1.14M +$4.26M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$1.9M +$2.55M +57.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$668K +$2.98M +81.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q3 2015 $56.6K -$3.12M +$976K +23.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$919K -$4.44M -$483K -12.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$436K -$3.65M -$2.06M -130% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 $1.63M $11.3M +$11.6M Oct 1, 2014 Dec 31, 2014 10-K 2015-02-27
Q3 2014 -$10M -$4.1M -$4.94K -0.12% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$10M -$3.96M -$919K -30.2% Apr 1, 2014 Jun 30, 2014 10-K 2015-02-27
Q1 2014 -$9.08M -$1.59M +$8.18M +83.8% Jan 1, 2014 Mar 31, 2014 10-K 2015-02-27
Q4 2013 -$17.3M -$365K -$3.47M -112% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 -$13.8M -$4.09M +$6.79M +62.4% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-27
Q2 2013 -$20.6M -$3.04M +$2.04M +40.1% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-27
Q1 2013 -$22.6M -$9.76M -$4.38M -81.3% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-27
Q4 2012 -$18.2M $3.11M +$10.3M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-17
Q3 2012 -$28.5M -$10.9M -$8.19M -304% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-17
Q2 2012 -$20.3M -$5.08M -$16.4M -145% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-17
Q1 2012 -$3.9M -$5.39M +$112K +2.04% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-17
Q4 2011 -$4.01M -$7.19M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 -$2.69M +$4.51M +62.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $11.4M +$13.8M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$5.5M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
Q3 2010 -$7.2M Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-11-14
Q2 2010 -$2.44M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.